A randomized, single-dose, dose-ascending, double blind, placebo-controlled, 5-way crossover study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled doses of GW642444M with magnesium stearate in asthmatic patients.
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Vilanterol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Mar 2007 to Apr 2007 as reported by Clinicaltrials.gov.
- 12 Oct 2008 Trial phase changed from I/II to I as reported by ClinicalTrials.gov.
- 18 Jul 2007 Status changed from recruiting to in progress.